Nationals pitcher Gio Gonzalez was named in the Miami New Times report as a patient of the Biogenesis clinic. It should be noted that the clinic records do not tie Gonzalez with any drugs that are on the MLB banned list.
That said, he will still likely be subject to whatever further investigation MLB mounts. In light of that, he has issued a statement, reported in the Washington Times:
“I’ve never used performance-enhancing drugs of any kind, and I never will. I’ve never met or spoken with Tony Bosch or used any substances provided by him. Anything said to the contrary is a lie.”
Unfortunately, similar past statements of players associated with PEDs have either proven to be false themselves or have gone unheeded in the rush to convict players of PED use in the court of public opinion whether evidence exists or not.
We must, however, take Gonzalez at his word for now and not throw him into the pile of known PED users unless or until there is evidence to do so. I know many fans and members of the media can’t keep from doing so, but to do anything else is simply wrong.
The Phillies and Red Sox appear intent on pursuing free agent first baseman Carlos Santana, MLB Network’s Jon Morosi reports. Santana rejected a one-year, $17.4 million qualifying offer from the Indians on Thursday and is expected to draw widespread interest on the market this winter. The Mets, Mariners, Angels and Indians could make a play for the infielder, though no serious offers have been made this early in the offseason.
Santana, 31, is coming off of a seven-year track with the Indians. He batted .259/.363/.455 with 23 home runs and 3.0 fWAR last season, making 2017 the fourth-most valuable year of his career to date. Although he was primarily stationed at first base over the last year, he could step back into a hybrid first base/DH role with the Red Sox, who are hurting for infield depth with Hanley Ramirez still working his way back from shoulder surgery.
As for Santana’s other suitors, the Mariners are far less likely to pursue a deal after trading for Ryon Healy last Wednesday. Neither the Mets nor the Phillies have a DH spot to offer the veteran infielder, and the Phillies’ Rhys Hoskins appears to be blocking the way at first base. Then again, Santana may not find a more enticing offer outside of Cleveland, where Edwin Encarnacion might otherwise be the club’s best option at first base. During the GM meetings, Indians’ GM Mike Chernoff said he “love to have both [Santana and Jay Bruce] back” in 2018, but hasn’t backed up that love with any contract talks just yet.